Changes in co-therapies after initiation of disease-modifying anti-rheumatic drugs (DMARDs) therapy in patients with rheumatoid arthritis

OBJECTIVES: We hypothesized that initiation of a new disease modifying anti-rheumatic drug DMARD) for rheumatoid arthritis (RA) treatment would decrease use of corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs) and narcotics. METHODS: Using administrative databases we assembled 4 retrosp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kawai, Vivian K., Grijalva, Carlos G., Arbogast, Patrick G., Curtis, Jeffrey R., Solomon, Daniel H., Delzell, Elizabeth, Chen, Lang, Ouellet-Hellstrom, Rita, Herrinton, Lisa, Liu, Liyan, Mitchell, Edward F., Stein, C. Michael, Griffin, Marie R.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227007/
https://ncbi.nlm.nih.gov/pubmed/22121511
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars